Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
종목 코드 AMIX
회사 이름Autonomix Medical Inc
상장일Jan 29, 2024
CEOHauser (Bradley)
직원 수8
유형Ordinary Share
회계 연도 종료Jan 29
주소21 Waterway Ave, Suite 300
도시THE WOODLANDS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호77380
전화18322777816
웹사이트https://autonomix.com/
종목 코드 AMIX
상장일Jan 29, 2024
CEOHauser (Bradley)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음